• 1. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 2. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 3. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 4. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis
• 5. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789

Chemical Profile of 1-Bromo-2,5-dimethoxy-4-nitrobenzene (CAS No. 98545-68-7)

1-Bromo-2,5-dimethoxy-4-nitrobenzene, identified by its Chemical Abstracts Service (CAS) number 98545-68-7, is a specialized organic compound that has garnered significant attention in the field of synthetic chemistry and pharmaceutical research. This compound belongs to the class of nitroaromatics and brominated phenols, exhibiting a unique structural framework that makes it a valuable intermediate in the synthesis of various bioactive molecules.

The molecular structure of 1-Bromo-2,5-dimethoxy-4-nitrobenzene consists of a benzene ring substituted with a bromine atom at the 1-position, methoxy groups at the 2- and 5-positions, and a nitro group at the 4-position. This particular arrangement of functional groups imparts distinct chemical reactivity, making it a versatile building block for further derivatization. The presence of both electron-withdrawing (nitro) and electron-donating (methoxy) groups creates a balance of reactivity that is highly useful in medicinal chemistry applications.

In recent years, 1-Bromo-2,5-dimethoxy-4-nitrobenzene has been extensively studied for its potential applications in the development of novel therapeutic agents. One particularly intriguing area of research involves its use as a precursor in the synthesis of small-molecule inhibitors targeting various biological pathways. For instance, studies have demonstrated its utility in generating compounds that interact with enzymes involved in cancer metabolism. The nitro group can be reduced to an amine, allowing for further functionalization into more complex structures that exhibit pharmacological activity.

Moreover, the bromine substituent at the 1-position provides a handle for cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings, which are pivotal in constructing biaryl frameworks found in many drug candidates. These reactions enable the introduction of diverse aryl moieties, expanding the chemical space available for drug discovery. The dimethoxy groups enhance solubility and metabolic stability, making derivatives more amenable for biological evaluation.

Recent advances in computational chemistry have further highlighted the significance of 1-Bromo-2,5-dimethoxy-4-nitrobenzene as a key intermediate. Molecular modeling studies suggest that derivatives of this compound can effectively modulate protein-protein interactions relevant to inflammatory diseases. By strategically modifying the positions of additional functional groups, researchers have been able to design molecules with enhanced binding affinity and selectivity. This approach aligns with the growing trend toward structure-based drug design, where computational predictions guide experimental synthesis.

The pharmaceutical industry has also explored 1-Bromo-2,5-dimethoxy-4-nitrobenzene as a scaffold for antiviral and antibacterial agents. The nitro group’s ability to participate in hydrogen bonding interactions has been leveraged to develop compounds that disrupt viral replication mechanisms. Additionally, the bromine atom’s reactivity allows for easy removal or replacement, facilitating the optimization of pharmacokinetic properties such as bioavailability and half-life.

In academic research circles, 1-Bromo-2,5-dimethoxy-4-nitrobenzene continues to serve as a model compound for understanding reaction mechanisms and developing new synthetic methodologies. Its unique reactivity profile has inspired innovative approaches to aromatic substitution and functional group interconversion. For example, recent publications detail catalytic systems that enable regioselective modifications at multiple positions on the benzene ring simultaneously—a feat that would be challenging with less versatile precursors.

The industrial production of 1-Bromo-2,5-dimethoxy-4-nitrobenzene adheres to stringent quality control measures to ensure consistency for research applications. Manufacturers employ advanced purification techniques such as column chromatography or recrystallization to isolate high-purity material. This commitment to quality is essential given its role in sensitive synthetic transformations where impurities can significantly impact yields and downstream applications.

Looking ahead, the future prospects for 1-Bromo-2,5-dimethoxy-4-nitrobenzene are promising as new methodologies emerge in synthetic organic chemistry and drug discovery. Its adaptability as an intermediate positions it well within emerging trends toward greener chemistry and high-throughput screening platforms. As computational tools become more sophisticated and automation improves reaction conditions, compounds derived from this scaffold are likely to play an even greater role in developing next-generation therapeutics.

• 60671-89-8(1-(2-Bromophenoxy)-2-nitrobenzene)
• 116163-99-6(1-bromo-2,5-dibutoxy-4-nitrobenzene)
• 115929-59-4(2-Bromo-4-methoxy-6-nitrobenzenol)
• 778599-56-7(Benzene, 1-bromo-2,4-dimethoxy-5-nitro-)
• 352205-02-8(Benzene, 1,5-bis(2-bromophenoxy)-2,4-dinitro-)
• 883106-34-1(1-(3-Bromophenoxy)-2-nitrobenzene)
• 25314-99-2(1-Bromo-2,6-dimethoxy-5-nitronaphthalene)
• 55034-12-3(Benzene,1-bromo-2,5-dimethoxy-3-nitro-)
• 98775-19-0(2-bromo-6-nitroanisole)
• 103966-66-1(5-Bromo-2-nitroanisole)